New Clinical Trials Data Bank

Publication
Article
OncologyONCOLOGY Vol 14 No 5
Volume 14
Issue 5

The National Library of Medicine has started posting information about clinical trials in its new Clinical Trials

The National Library of Medicine has started posting information about clinical trials in its new Clinical Trials Data Bank (http://clinicaltrials.gov). At present, the new bank contains more data than had formerly been available on the NIH clinical trials website, and it will be expanded throughout 2000 to include trials sponsored by other federal agencies and the private sector. The trials included in the new data bank are only those conducted under an FDA investigational new drug application for serious or life-threatening diseases, such as cancer or AIDS. In conjunction with establishment of the data bank, the FDA has published draft guidance on what kind of information clinical trial sponsors must submit (www.fda.gov/cder/guidance/index.htm).

Recent Videos
Elucidating nonresponses to bispecific T-cell engagers may be an important research consideration in the multiple myeloma field.
Barriers to access and financial toxicities are challenges that must be addressed for CAR T-cell therapies in LBCL, according to Jose Sandoval Sus, MD.
Fixed treatment durations with bispecific antibodies followed by observation may help in mitigating infection-related AEs, according to Shebli Atrash, MD.
2 experts are featured in this series.
Epistemic closure, broad-scale distribution, and insurance companies are the 3 largest obstacles to implementing new peritoneal surface malignancy care guidelines into practice.
2 experts are featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Shebli Atrash, MD, stated that MRD should be considered carefully as an end point, given potential recurrence despite MRD negativity.
Related Content